A theory of convulsive therapy in endogenous depression: significance of hypothalamic functions

Psychiatry Research
M Fink, J O OTTOSSON

Abstract

The repeated induction of seizures (convulsive therapy) relieves the symptoms of severe depressive mood disorders, particularly those accompanied by vegetative symptoms. Neuroendocrine abnormalities characterize patients with endogenous depression, and the abnormalities are reversed by convulsive therapy. Tests of neuroendocrine functions provide criteria for the classification of such cases, and probably will be useful in defining suitable cases for convulsive therapy. We postulate that the antidepressant efficacy of convulsive therapy results from the increased release and more widespread cerebral distribution of hypothalamic peptides with behavioral effects. Such a hypothesis provides a basis for clinical trials of centrally active peptides in cases of endogenous depression, and for studies of neuroendocrine functions as predictors of outcome in convulsive therapy.

References

May 1, 1977·The American Journal of Psychiatry·P G Ettigi, G M Brown
May 1, 1978·The American Journal of Psychiatry·R H Ehrensing, A J Kastin
May 1, 1978·Psychological Medicine·B T Donovan
Apr 1, 1978·Pharmacological Research Communications·A J KastinL H Miller
Oct 30, 1976·Lancet·R OhmanL Wallin
Jan 7, 1978·Lancet·J J LegrosP Berchier
Jan 7, 1978·Lancet·J C OliverosJ M Moeglen
Feb 4, 1978·Lancet·D G Grahame-SmithD W Costain
Mar 18, 1978·Lancet·D R BlakeJ G Evans
Jan 20, 1979·Lancet·M RaskindR E Weitzman
Oct 1, 1978·Archives of General Psychiatry·F BrambillaE E Müller
Jan 1, 1976·Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)·T J Martin
Aug 1, 1979·The American Journal of Psychiatry·F N Pitts, C W Patterson
Nov 1, 1977·The Journal of Physiology·J C Buckingham, J R Hodges
Jan 1, 1979·Pharmakopsychiatrie, Neuro-Psychopharmakologie·E Krebs, J Roubicek
Mar 1, 1979·Archives of General Psychiatry·W M VerhoevenD de Wied
Apr 1, 1977·European Journal of Clinical Investigation·T G BolwigO J Rafaelsen
Apr 1, 1977·European Journal of Clinical Investigation·T G BolwigJ Holm-Jensen
Jan 1, 1977·Psychoneuroendocrinology·F GrégoireJ Corvilain
Feb 1, 1978·The American Journal of Psychiatry·P T LoosenI C Wilson
Sep 1, 1979·The American Journal of Psychiatry·J F Greden, B J Carroll
May 1, 1979·Pharmakopsychiatrie, Neuro-Psychopharmakologie·N Nedopil, E Rüther
Dec 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·S A Checkley, J L Crammer
May 1, 1978·The American Journal of Psychiatry·J P O'DeaR G Wieland
Sep 1, 1975·Acta Psychiatrica Scandinavica·C KirkegaardN Bjorum
Jan 1, 1976·Pharmacology, Biochemistry, and Behavior·P T LoosenP P Lara
Feb 1, 1977·The American Journal of Psychiatry·G Asnis
Sep 1, 1977·Archives of General Psychiatry·N S KlineT Cooper
Mar 1, 1976·Hormones and Behavior·P Mason, E K Adkins
Sep 1, 1976·Archives of General Psychiatry· CarrollJ Mendels
May 1, 1976·Psychological Medicine·B J CarrollJ Mendels
Jul 1, 1975·The American Journal of Psychiatry·A H GlassmanM Shostak
Mar 1, 1975·The American Journal of Psychiatry·Z M Lebensohn, R B Jenkins

❮ Previous
Next ❯

Citations

Feb 1, 1981·Psychiatry Research·Y PapakostasL Johnson
Jan 1, 1982·Psychoneuroendocrinology·P S SørensenT G Bolwig
Jun 1, 1992·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M BankiC B Nemeroff
Oct 4, 2002·Biological Psychiatry·Carol A TammingaTrisha Suppes
Oct 27, 1998·Biological Psychiatry·D P DevanandH A Sackeim
Jul 10, 2002·Journal of Affective Disorders·E S M SaravananD K Subbakrishna
May 3, 2007·Psychiatry and Clinical Neurosciences·Hideki AzumaToshi A Furukawa
Nov 1, 1991·Acta Psychiatrica Scandinavica·M Fink
Mar 14, 2001·Journal of Affective Disorders·M Fink
Oct 1, 1996·International Journal of Technology Assessment in Health Care·B Mårtensson
May 1, 1993·Psychological Medicine·F J LetemendiaD W Lywood
Feb 7, 2007·Acta Psychiatrica Scandinavica. Supplementum·T G Bolwig, T M Madsen
Nov 1, 1990·Biological Psychiatry·M C WebbT R Sibert
Mar 6, 2010·Journal of Affective Disorders·Karl-Jürgen BärMarcus Willi Agelink
Jan 1, 1986·Annals of the New York Academy of Sciences·J W HoladayR J Hitzemann
Jan 1, 1986·Annals of the New York Academy of Sciences·T G Bolwig, O S Jørgensen
Jan 1, 1986·Annals of the New York Academy of Sciences·J O Ottosson
Apr 11, 2015·Trends in psychiatry and psychotherapy·Daniel Fortunato Burgese, Débora Pastore Bassitt
Nov 1, 1980·Acta Psychiatrica Scandinavica·T G Bolwig, O S Jørgensen
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·B ShapiraA Calev
Jul 30, 2019·Psychiatry Investigation·Heon-Jeong Lee
Jun 1, 1996·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·F R Lalla, T Milroy
Jan 1, 1986·Annals of the New York Academy of Sciences·J W HoladayR J Hitzemann
Jan 1, 1986·Acta Medica Scandinavica·M Thorén, S Werner
Feb 18, 2011·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tom G Bolwig
Jan 1, 2019·Journal of Affective Disorders·Takafumi WatanabeEisuke Matsushima
Nov 1, 1980·Comprehensive Psychiatry·M Fink

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved